Thermal Imaging in Diagnostics of Chronic Ulcers and in Monitoring Healing of Chronic Ulcers

NCT ID: NCT05931081

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-01

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with chronic ulcer needing tertiary care referred to the Wound Center of Tampere University Hospital are invited to this study. Patients are treated according to standard treatment practices. The temperature of the lower limbs and ulcer area is measured during visits using the Thermidas Remote thermal imaging system, a CE-marked medical device for measuring and monitoring changes in skin surface temperature non-invasively. The measured temperatures and differences are compared in different ulcer aetiology groups and analyzed whether thermal imaging can be used to distinguish atypical ulcers from vascular ulcers.

Thermal imaging measurements and clinical examinations are repeated to the patients with atypical ulcers during follow-up visits. Monitoring of ulcers will continue until the ulcer has epithelized completely or for up to a year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

4A: Patients with chronic ulcer i.e. venous, arterial or mixed ulcers or atypical (vasculitic or pyoderma gangraenosum) ulcers needing tertiary care referred to the Wound Center of Tampere University Hospital are invited to this study. Aim is to recruit about 20 patients of each group of ulcers. Patients are treated according to standard treatment practices. The temperature of the lower limbs and ulcer area is measured during visits in a standardized measuring environment from both limbs using the Thermidas Remote thermal imaging system (ThRemote 1.3.1, Remote SW with FLIR Inc's series T IR cameras, Thermidas Oy), a CE-marked medical device for measuring and monitoring changes in skin surface temperature non-invasively. The temperature of the ulcer area is compared with the temperature of the corresponding skin area of the other limb and the temperature difference (delta) of the areas is determined. The measured temperatures and differences are compared in different ulcer aetiology groups and analyzed whether thermal imaging can be used to distinguish atypical ulcers from vascular ulcers.

4B: Thermal imaging measurements and clinical examinations are repeated to the patients with atypical ulcers during follow-up visits, and the change in the measurement of temperatures with thermal imaging is compared with the clinician's assessment of the ulcer status (size, ulcer's border activity, necrosis, and pain intensity) and its changes during follow-up visits. Monitoring of ulcers will continue until the ulcer has epithelized completely or for up to a year.

Actual sample size calculations cannot be made, because previous studies on thermal imaging in patients with atypical ulcers have not been published. Based on previous studies, it can be assumed, that statistically significant differences will be obtained between the study groups of approximately 20 subjects. This is a pilot study, and if the study gives promising results, further research will be carried out in the future with more extensive data.

Clinical implication: If thermal imaging is useful in assessing the tendency of ulcer healing, it can be used to optimize the treatment of ulcer patient, such as considering the timing immunosuppressive treatment or skin graft surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Ulcer of Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thermal imaging in diagnostics of chronic ulcers

atypical: vasculitic or pyoderma gangraenosum ulcers

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

venous, arterial or mixed ulcers or atypical ulcers

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with chronic ulcer i.e. venous, arterial or mixed ulcers or atypical (vasculitic or pyoderma gangraenosum) ulcers needing tertiary care referred to the Wound Center of Tampere University Hospital are invited to this study.

Exclusion Criteria

* Patients with more than one wound etiology in the examined wound (except mixed ulcer) are excluded from the study.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tampere University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Teija Kimpimäki, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Tampere University Hospital, University of Tampere

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tampere University Hospital

Tampere, , Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R22108L

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diabetic Foot Ulcer Imaging- Study 2
NCT03942081 RECRUITING NA